coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Salford South East PCN, Salford (LAD) · Health Inequalities Profile

    PCN U60510 · NHS Greater Manchester Integrated Care Board · 10 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    95,394

    Registered population

    75.7% aged 18–64

    8.8%

    Aged 65+

    ICB 14.9% · England 17.9%

    45.2%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~33,732

    Core20 residents (est.)

    Resident basis; registered basis ~44,262 · see page 3

    8,464

    Hypertension register

    +0.38% in 3 yrs · England +5.60%

    1,072

    SMI register

    28.9% of Salford (LAD)'s

    2,229

    COPD register

    Reviews +19.70% in 3 yrs

    Forecast to 2030

    9,020

    Hypertension patients, 2030

    +556 on today

    68.8%

    QRISK ≥20% on statins, 2030

    +1.16pp over 3 yrs

    2.2%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    +30.3%
    Asthma review coverage grew faster than comparators.

    Asthma annual reviews grew +30.3% from 2023 to 2025 (England +4.4%; Salford +18.5%), reaching 68.4% against 65.7% in England.

    -6.3%
    Stroke register contracted against comparator growth.

    Stroke QOF prevalence changed by -6.3% from 2023 to 2025 (England +2.3%) to 1.3%, which may reflect coding or the 8.8% aged 65+ share.

    56.3%
    Cervical screening coverage at ages 25-49 trails England.

    Cervical screening at ages 25-49 is 56.3%, below Salford (62.7%), the ICB (65.9%) and England (66.8%), which may reflect recall or access barriers.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Across 95,394 registered patients, 75.7% are aged 18–64 and 8.8% aged 65+

    Salford South East PCN serves 95,394 registered patients. Adults aged 18–64 represent 75.7% (72,235 patients), exceeding Salford (LAD) at 64.8%, NHS Greater Manchester Integrated Care Board at 63.3%, and England at 62.7%. Those aged 65+ account for 8.8% (8,378 patients), below Salford (LAD) at 14.4%, the ICB at 14.9%, and England at 17.9%. Census estimates record 0.3% Roma and 0.2% Gypsy or Irish Traveller residents. Projected population growth to 2030 is 2.7% (Salford (LAD) 1.7%, ICB 1.6%, England 2.3%), though projection methodology is unverified. Age counts reflect registered patients, whereas ethnicity uses Census resident estimates.

    Age profile

    0–1715.5%
    18–6475.7%
    65+8.8%

    65+: ICB 14.9%, England 17.9%

    Older people · falls rows are Salford (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Salford LA)2,9802,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)86.5%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)60.6%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Salford LA)1,5101,0219552024/25
    Falls deaths, all ages, per 100,000 (Salford LA)15.718.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 coverage reaches 45.2% and concentration varies sharply across practices

    Salford South East PCN has an average IMD decile of 3.7 (Salford 3.9, ICB 4.5, England 5.5) and 45.2% of registered patients in Core20 areas, above Salford (44.0%), the ICB (40.7%) and England (21.0%). Across practices, concentration spans a 69.7 pp range, peaking at The Willows Medical Practice (78.8%) and Cornerstone Medical Practice (71.1%). However, volume concentrates at Langworthy Medical Practice (10,935 estimated Core20 patients) and 1/salford Medical Practice (6,271). Practice estimates sum to 44,262 against 33,732 resident Core20 patients, requiring denominator reconciliation.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Willows Medical78.8% · 2,747 patients
    Cornerstone71.1% · 2,869 patients
    Pendleton66.5% · 6,253 patients
    Langworthy60.7% · 10,935 patients
    Clarendon52.7% · 5,928 patients
    Sorrel Bank41.2% · 3,328 patients
    1/salford Medical38.0% · 6,271 patients
    Ordsall Health33.8% · 3,790 patients
    Height General22.6% · 1,543 patients
    Orient Road9.1% · 598 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    1,072

    SMI register

    1.15% recorded prevalence

    338

    Learning disability register

    0.36% recorded prevalence

    13

    Care homes, 330 beds

    In the PCN catchment

    9.2%

    Provide unpaid care

    Salford (LAD), Census 2021

    The PCN records 1,072 patients on the severe mental illness register (1.1% versus Salford (LAD) 1.1% and England 1.0%), representing 28.9% of the borough register, and 338 patients on the learning disability register (0.4% versus England 0.6%). Catchment capacity includes 13 care homes with 330 beds.

    Severe mental illness: physical health checks

    SMI prevalence is 1.1% (England 1.0%). While annual BMI checks reach 88.1% (England 82.1%), blood pressure checks stand at 81.9%, trailing England (83.4%) and Salford (84.7%). Check components show strong BMI tracking but lagging blood pressure monitoring.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    8,464

    Hypertension register

    +0.38%

    Register growth, 3 yrs

    Salford (LAD) +5.45% · England +5.60%

    +6.57pp

    BP control, under 80

    ≤140/90 · +4.45pp aged 80+

    +556

    More patients by 2030

    Forecast 9,020 (9.15%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 9.1% (8,464 patients), below Salford (12.4%), NHS Greater Manchester ICB (14.4%) and England (15.2%), with three-year growth of +0.4% trailing England (+5.6%). This lower crude rate is consistent with a younger list (8.8% aged 65+ versus England 17.9%), though case-finding variation cannot be excluded. Once registered, clinical control is strong: 92.4% have a recent blood pressure reading (England 90.0%) and 75.7% are treated to target (England 70.3%). Lower register growth alongside strong treatment control may reflect younger demographics or case-finding gaps, testable via age-standardised audits.

    Lipids and statins

    For patients with QRISK ≥ 20%, 66.4% receive lipid-lowering therapy, above England (63.6%), but three-year growth (+1.8%) lags England (+6.2%). In contrast, lipid prescribing for patients aged 65+ reaches 16,593 per 1,000, exceeding Salford (14,002). Slower therapy expansion than England among patients with QRISK ≥ 20% highlights an opportunity to review cardiovascular risk recalls.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026139,019£1.30£1.94£1.86£180,725
    Cardiovascular (all), 2025195,745£2.34£3.15£3.33£458,043

    In 2026, the PCN prescribed 139,019 lipid-regulating items at £1.30 per item, below Salford (£1.54), NHS Greater Manchester ICB (£1.94) and England (£1.86), which is £77,851 less than at England's unit cost across these items. Lower unit cost reflects formulary choices or case-mix rather than proven efficiency, providing context for prescribing spend.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +30.29%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −4.94%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 5.0% (England 6.6%), falling 4.9% from 2023 to 2025 (England +0.5%). COPD prevalence is 2.4% (England 1.9%), falling 2.6% (England +2.6%). Meanwhile, 12-month asthma reviews reached 68.4% (England 65.7%), leaving an estimated 1,391 patients unreviewed across the 4,408 register (a scale indicator). Asthma prescribing reached 2,152 items per 1,000 aged 5-19 (England 1,488). Contracting registers alongside higher youth prescribing may reflect diagnostic variation, testable by clinical audit.

    Cancer register and children's immunisation

    Cancer prevalence is 2.1% (England 3.8%), rising +3.7% from 2023 to 2025 (England +9.0%). In Q1 2025/26 childhood immunisations, MMR dose 1 at age five reached 95.0% (England 91.7%), but dose 2 was 84.2% (England 82.8%), a 10.8 pp same-cohort difference across 222 children. The second-dose gap may reflect recall barriers, testable by practice-level vaccination audits.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months92.0%

    England 91.0%

    6-in-1 complete primary course at 24 months90.9%

    England 92.2%

    MMR dose 1 at 24 months87.5%

    England 88.3%

    MMR dose 2 at age 584.2%

    England 82.8%

    4-in-1 pre-school booster at age 585.6%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    In 2022, 55.6% of staged cancers across NHS Greater Manchester ICB were diagnosed at stage 1 or 2 (6,491 of 11,679 known-stage cases; England 55.3%), sitting 19.4 pp below the 75.0% national ambition. Known stage was recorded for 70.8% of 16,492 cancers; staging is not published at PCN level. Reaching 75.0% requires about 2,270 additional early diagnoses across the ICB, where early diagnosis rose +3.1 pp from 2013 to 2022. Locally, PCN cervical screening is 56.3% (England 66.8%) and breast screening is 61.2% (England 69.9%). Lagging primary care screening uptake may reduce early detection opportunities across wider system pathways.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    Northern Care Alliance NHS Foundation Trust exceeded the 75.0% 28-day faster diagnosis standard by 0.2 pp (75.2044%), but fell 6.4 pp below the 85.0% 62-day referral standard at 78.6486% and 1.5 pp below the 96.0% 31-day standard at 94.5402%. Across NHS Greater Manchester Integrated Care Board, 28-day diagnosis reached 79.5261% (4.5 pp above) and 31-day treatment was 96.4937% (0.5 pp above), while 62-day referral was 9.3 pp below standard at 75.7262%. Slower treatment commencement following referral may prolong overall cancer pathways despite meeting the faster diagnosis standard.

    Pathways within standard (%)Northern Care AllianceManchesterBoltonGreater Manchester ICBEngland
    28-day faster diagnosis (75%)75.2080.0680.4879.5379.32
    31-day treatment (96%)94.5492.5496.5096.4992.50
    62-day referral to treatment (85%)78.6572.8569.6675.7371.16
    Diagnostic waits over 6 weeks (%)Northern Care AllianceManchesterBoltonEngland
    MRI5.0911.682.0521.40
    CT4.1014.6619.409.92
    Echocardiography31.484.913.4828.48
    Colonoscopy40.044.511.3330.83
    Gastroscopy36.4829.352.0629.02
    All 15 DM01 tests15.718.9815.7823.14
    Community services activitySalford residentsGreater Manchester ICB
    Care contacts37,955573,310
    Referrals3,34094,470
    Patients with a contact15,440183,535

    Community services (residents of Salford), Jun 2026 (provisional). In provisional June 2026 data, adults aged 65 and over accounted for 53.9% of community service contacts among borough residents (20,470 of 37,955 contacts). Substantial older-adult community activity provides an entry point to coordinate local frailty reviews with early diagnostic pathways.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Patient phone access varies across practices by 27.4 pp, alongside uneven vaccination achievement

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Orient Road1119.181.6%77.4%87.7%
    Cornerstone11871.183.6%88.4%87.3%
    Sorrel Bank11641.256.3%83.1%83.0%
    Ordsall Health12233.865.3%80.8%81.5%
    Clarendon Surgery10152.767.8%64.4%80.5%
    Langworthy12160.759.1%73.2%79.0%
    1/salford Medical11338.079.6%77.4%78.9%
    Willows Medical10678.882.4%70.3%77.6%
    Height General12822.666.0%72.1%76.3%
    Pendleton10466.561.8%77.3%72.8%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNSalford (LAD)AssetPCNSalford (LAD)
    Care homes (catchment)13 (330 beds)n/aSchools (catchment)93n/a
    Children's centres616Places of worship33118
    Libraries516Primary schools (LA maintained)1752
    Primary academies521

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Stroke register and coding audit

    Recorded stroke prevalence is 1.3% (1,213 patients) versus Salford (LAD) 1.7% and England 1.9%, falling 6.3% from 2023 to 2025 (England +2.3%), with a modelled unadjusted gap range of +419 to +589. Low cost, quick to run.

    Evidence base: the stroke/TIA register is the cohort for AF anticoagulation and blood-pressure control (pre-stroke prevention) as well as hyperacute care; practices well below expected prevalence are the case-finding list, and the pre-stroke prevention gap concentrates in deprived practices.

    Policy anchor: Core20PLUS5 (CVD); NHS CVD ambitions to 2029.

    Option 2

    Learning disability register validation

    Learning disability prevalence is 0.4% (338 patients) versus Salford (LAD) 0.5% and England 0.6%, falling 1.1% from 2023 to 2025 (England +5.4%), with a modelled gap range of +129 to +223. For discussion: practices could audit historical diagnostic codes and cross-check registers where local social-care data-sharing agreements exist. Moderate effort to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Option 3

    Structured asthma annual review recall

    Annual asthma reviews reached 68.4% (above England 65.7%, but 3.2 pp below Salford (LAD) 71.6%), leaving an estimated 1,391 of 4,408 registered patients without a recorded 12-month review. For discussion: practices could standardise recall templates, align inhaler prescribing checks with annual reviews, and offer flexible appointment slots. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI cardiovascular check recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension case-finding audit (p5)Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school MMR recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening uptake outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice telephony and triage review (p9)GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · Stroke register and coding audit (p12)Stroke register · Stroke: QOF prevalence · Aged 65+Core20PLUS5 CVD · CVDPREVENT · SSNAPPCN
    Option 2 · Learning disability register validation (p12)Learning disability register · Learning disability: QOF prevalence · Registered population75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Option 3 · Structured asthma annual review recall (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15